Positron Corporation
 |
|
| Public | |
| Traded as | OTC Pink: |
| Industry | Nuclear Medicine |
| Founded | (1983) |
| Headquarters | Westmont, Illinois, U.S.A |
| Products | Nuclear medical imaging devices |
| Subsidiaries | Positron Isotopes Corporation Manhattan Isotope Technology |
| Website |
www www |
Positron Corporation is an American nuclear medicine healthcare company specializing in cardiac Positron Emission Tomography (PET) imaging. Positron operates in a variety of business areas combining cardiac PET imaging technology, radiopharmaceuticals and radioisotopes. Positron is headquartered in Westmont, Illinois and holds three facilities: a radioisotope manufacturing facility in Lubbock, Texas, a clinical and technical cardiovascular PET training institute in Niagara Falls, New York and an automation manufacturing facility in Fishers, Indiana.
The company's products and services enable healthcare providers to diagnose cardiac disease and improve patient outcomes. Positron Corporation is a public company and traded on the Financial Industry Regulatory Authority, Inc.'s OTC Bulletin Board under the ticker symbol POSC.
Positron was founded in 1983 as a research and development company. The company expanded from a medical imaging device manufacturer to a nuclear healthcare company integrating the key components of the cardiac PET supply chain. Positron's strategy focuses on stabilizing and securing the Sr-82 supply chain.
In January 2012, Positron acquired Manhattan Isotope Technology. This subsidiary focuses on increasing Sr-82 supply by processing proton irradiated target material, recycling Sr-82 from spent generators, and through its pursuit of procuring a 70 MeV cyclotron.
After its founding in 1983, Positron debuted a new time-of-flight tomograph called the POSICAM. Posicam used barium fluoride for the scintillation detector and was primarily used by researchers interested in cardiac imaging. In 1985, the FDA approved the POSICAM system for marketing and the following year, Positron began commercial operations. The FDA later gave approval to Positron to begin marketing its HZ PET imaging system in 1991. Positron received patents for aspects of its HZ and HZL POSICAM systems in 1993 along with FDA approval to market HZL.
...
Wikipedia